DOCSLIB.ORG

Gynaecology Healthcare Atlas 2015–2017 Helseatlas Hospital Referral Areas and Adjustment SKDE

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Gynaecology Healthcare Atlas 2015–2017 Helseatlas Hospital Referral Areas and Adjustment SKDE Gynaecology Healthcare Atlas 2015–2017 Helseatlas Hospital referral areas and adjustment SKDE The following fact sheets use the terms ‘hospital referral area’ and ‘adjusted for age’. These terms are explai- ned below. Aver. Hospital referral areas Inhabitants age Akershus 67% 201,911 47.2 The regional health authorities have a responsibility to provide satis- Vestre Viken 64% 196,644 48.6 Bergen 67% 178,531 46.7 factory specialist health services to the population in their catchment Innlandet 59% 166,569 50.3 area. In practice, it is the individual health trusts and private provi- Stavanger 70% 140,197 45.6 St. Olavs 66% 127,895 46.9 ders under a contract with a regional health authority that provide and Sørlandet 64% 120,307 47.8 Østfold 62% 119,927 49.2 perform the health services. Each health trust has a hospital referral OUS 72% 109,435 45.0 area that includes specific municipalities and city districts. Different Møre og Romsdal 61% 104,957 49.0 Vestfold 61% 95,564 49.3 disciplines can have different hospital referral areas, and for some ser- UNN 63% 77,413 48.2 Telemark 60% 71,665 49.8 vices, functions are divided between different health trusts and/or pri- Fonna 63% 70,749 48.2 vate providers. The Gynaecology Healthcare Atlas uses the hospital Hospital referral area Lovisenberg 84% 62,639 38.6 Diakonhjemmet 67% 59,811 46.3 referral areas for specialist health services for medical emergency ca- Nordland 61% 56,144 49.0 Nord-Trøndelag 61% 55,459 49.3 re. Førde 60% 43,540 49.4 Helgeland 60% 56+ years 31,821 49.7 In the period 2015–2017, there were, on average, about 2.12 million Finnmark 64% 16-55 years 30,108 47.8 women aged 16 years or older in Norway. As shown in the figure, 0 50,000 100,000 150,000 200,000 the size of the population of the health trusts’ hospital referral areas Number Source: SSB varied considerably. The average age of the female population also varied between hospital referral areas. Number of women aged 16 years or older living in Norway, broken down by hospital referral area and age group. Average for the period 2015–2017. The table below shows the health trusts or hospitals for which hospital referral areas have been defined and the short versions of the names Adjustment for age used in the fact sheets and report. In order to compare the number of events in different hospital referral areas, the actual numbers have been standardised by age. The standar- disation was based on the direct method, using the female population Health trust/hospital Short name of Norway in the relevant age range in 2016 as the reference popula- Northern Norway Regional Health Authority tion. The age groups are defined in such a way that there are about the Finnmark Hospital Trust Finnmark same number of events in each age group. The age group division will University Hospital of Northern Norway Trust UNN Nordland Hospital Trust Nordland consequently vary between different samples. The analysis shows the Helgeland Hospital Trust Helgeland number of events per 10,000 women that the hospital referral areas would have had if the age composition of their female population we- Central Norway Regional Health Authority re identical to that of the country as a whole in 2016. Helse Nord-Trøndelag health trust Nord-Trøndelag St. Olavs Hospital Trust St. Olavs The standardised number of events per 10,000 women in hospital re- Helse Møre og Romsdal health trust Møre og Romsdal ferral area j is calculated as follows: Western Norway Regional Health Authority Helse Førde health trust Førde K Helse Bergen health trust Bergen X nij rj = 10; 000 × × ai Helse Fonna health trust Fonna Nij Helse Stavanger health trust Stavanger i=1 South-Eastern Norway Regional Health Authority with nij being the actual number of events in hospital referral area j Østfold Hospital Trust Østfold and age group i, Nij being the population of hospital referral area j Akershus University Hospital Trust Akershus in age group i, ai the national proportion that age group i makes up Oslo University Hospital Trust OUS of the female population of Norway in 2016 and K being the number Lovisenberg Diaconal Hospital Lovisenberg Diakonhjemmet Hospital Diakonhjemmet of age groups. Innlandet Hospital Trust Innlandet Proportions standardised for age are presented in some analyses. In Vestre Viken Hospital Trust Vestre Viken Vestforld Hospital Trust Vestfold these cases, age-standardised numbers per 10,000 women are used in Telemark Hospital Trust Telemark both the numerator and denominator. Sørlandet Hospital Trust Sørlandet For a complete list of the municipalities and city districts that make up the different hospital referral areas, see the appendix tothe report. With some exceptions, the hospital referral areas are defined in the same way as in the annual SAMDATA reports. For more information see the report or www.helseatlas.no.
Load more

Recommended publications
  • Annual Report 2020
    Annual Report Research Activity 2020 Division of Clinical Neuroscience University of Oslo and Oslo University Hospital 0 Contents Oslo University Hospital and the University of Oslo .................................................................................. 4 Division of Clinical Neuroscience .............................................................................................................. 4 Division of Clinical Neuroscience (NVR) Organizational Chart ................................................................... 5 Department of Physical Medicine and Rehabilitation Rehabilitation after trauma..................................................................................................................... 6 Group Leader: Nada Andelic Painful musculoskeletal disorders ........................................................................................................... 10 Group Leader: Cecilie Røe Department of Refractory Epilepsy - National Centre for Epilepsy Complex epilepsy ................................................................................................................................... 11 Group Leader: Morten Lossisus Department of Neurosurgery Neurovascular-Cerebrospinal Fluid Research Group ............................................................................. 17 Group Leader: Per Kristian Eide Oslo Neurosurgical Outcome Study Group (ONOSG) ................................................................................ 20 Group Leader: Eirik Helseth and Torstein Meling Vilhelm
    [Show full text]
  • Detailed-Program-6Th-Ocher-2017
    6th OCHER workshop on Clinical Communication Research January 11-13, 2017 The Oslo Communication in Healthcare Education and Research (OCHER) group The aims of OCHER workshops are two: 1) To provide a fruitful arena for discussion of research projects at all stages of development, with particular attention to challenges in methodology 2) To build a Scandinavian network (with international collaboration partners) of multidisciplinary researchers with interest in communication in health care Program Start: Wednesday 11 January, 10:00 End: Friday 13 January, 16:00 Venue: Thon Hotel Triaden, Lørenskog, Norway Address: Gamleveien 88 1476 Rasta Telephone: +47 66 10 97 00 Lecturers and group discussants: Professor J. Randall Curtis, University of Washington, Seattle, USA Keynote titles: - Measuring and improving communication about palliative care: What have we learned and where do we go from here? - Communication and decision-making with families of critically ill patients: Lessons from the successes and failures Professor Vikki Entwistle, University of Aberdeen, Scotland, UK Keynote titles: - Support for self-management among people with long-term conditions: re-formulating the concept to reflect and promote good practice - “How will we know if I’ve done a good job?” The challenges of evaluating person- centred care Local faculty: Pål Gulbrandsen, Arnstein Finset, and Jan Svennevig, University of Oslo, Hilde Eide, University College of Southeast Norway, Jennifer Gerwing, Akershus University Hospital Working languages: English, Scandinavian Page 1 of 36 Wednesday January 11 Time Activity Plenary room / Room A Room B 1000 Plenary Introduction, mutual presentation 1045 Break 1100 Plenary Vikki Entwistle Support for self-management keynote 1 among people with long-term conditions: re-formulating the concept to reflect and promote good practice 1230 Lunch 1315 Plenary J.
    [Show full text]
  • Norwegian Journal of Epidemiology Årgang 27, Supplement 1, Oktober 2017 Utgitt Av Norsk Forening for Epidemiologi
    1 Norsk Epidemiologi Norwegian Journal of Epidemiology Årgang 27, supplement 1, oktober 2017 Utgitt av Norsk forening for epidemiologi Redaktør: Trond Peder Flaten EN NORSKE Institutt for kjemi, D 24. Norges teknisk-naturvitenskapelige universitet, 7491 Trondheim EPIDEMIOLOGIKONFERANSEN e-post: [email protected] For å bli medlem av Norsk forening for TROMSØ, epidemiologi (NOFE) eller abonnere, send e-post til NOFE: [email protected]. 7.-8. NOVEMBER 2017 Internettadresse for NOFE: http://www.nofe.no e-post: [email protected] WELCOME TO TROMSØ 2 ISSN 0803-4206 PROGRAM OVERVIEW 3 Opplag: 185 PROGRAM FOR PARALLEL SESSIONS 5 Trykk: NTNU Grafisk senter Layout og typografi: Redaktøren ABSTRACTS 9 Tidsskriftet er åpent tilgjengelig online: LIST OF PARTICIPANTS 86 www.www.ntnu.no/ojs/index.php/norepid Også via Directory of Open Access Journals (www.doaj.org) Utgis vanligvis med to regulære temanummer pr. år. I tillegg kommer supplement med sammendrag fra Norsk forening for epidemiologis årlige konferanse. 2 Norsk Epidemiologi 2017; 27 (Supplement 1) The 24th Norwegian Conference on Epidemiology Tromsø, November 7-8, 2017 We would like to welcome you to Tromsø and the 24th conference of the Norwegian Epidemiological Association (NOFE). The NOFE conference is an important meeting point for epidemiologists to exchange high quality research methods and findings, and together advance the broad research field of epidemiology. As in previous years, there are a diversity of topics; epidemiological methods, cardiovascular disease, diabetes, cancer, nutrition, female health, musculo-skeletal diseases, infection and behavioral epidemiology, all within the framework of this years’ conference theme; New frontiers in epidemiology. The conference theme reflects the mandate to pursue methodological and scientific progress and to be in the forefront of the epidemiological research field.
    [Show full text]
  • Clinicians' Assumptions About Sami Culture and Experience Providing Mental Health Services to Indigenous Patients in Norway
    Assumptions about Sami culture… Clinicians’ assumptions about Sami culture and experience providing mental health services to Indigenous patients in Norway Inger Dagsvold, UiT The Arctic University of Norway Snefrid Møllersen, Finnmark Hospital Trust, Karasjok, Norway Bodil H. Blix, UiT The Arctic University of Norway Corresponding author: Inger Dagsvold Duevn. 16, 9015 Tromso, Norway [email protected] +47 97461330 1 Assumptions about Sami culture… Abstract This qualitative study explores Sami and non-Sami clinicians’ assumptions about Sami culture and their experiences in providing mental health services to Sami patients. The aim is to better understand and improve the ways in which culture is incorporated into mental health services in practice. Semi-structured interviews were conducted with 20 clinicians in mental health outpatient clinics in the northern Sami area in Troms and Finnmark County in Norway. The findings show that clinician’s conceptualization of culture influences how they take cultural considerations about their Sami patients into account. To better integrate culture into clinical practice, the cultures of both patient and clinician, as well as of mental health care itself need to be assessed. Finally, the findings indicate a lack of professional team discussions about the role of Sami culture in clinical practice. Keywords: Sami, Norway, qualitative research, mental health service, cultural adaption, indigenous. 2 Assumptions about Sami culture… Introduction Culture matters in mental healthcare because it shapes the experience and expression of mental health problems, as well as health-related beliefs, help-seeking behaviors and ideas about treatment (Helman, 2007; Kirmayer, 2012; Kleinman & Benson, 2006). Cultural differences are often used as an explanation for why minority populations and indigenous people are less satisfied with health services than majority populations (Alizadeh & Chavan, 2016; King, Smith, & Gracey, 2009).
    [Show full text]
  • Annual Report Research Activity 2019
    Annual Report Research Activity 2019 Division of Clinical Neuroscience University of Oslo and Oslo University Hospital 0 Contents Oslo University Hospital and the University of Oslo .................................................................................... 4 From Division Director Eva Bjørstad ........................................................................................................... 4 Division of Clinical Neuroscience (NVR) Organizational Chart ..................................................................... 5 Department of Physical Medicine and Rehabilitation Rehabilitation after trauma....................................................................................................................... 6 Group Leader: Nada Andelic Painful musculoskeletal disorders .............................................................................................................. 9 Group Leader: Cecilie Røe Department of Refractory Epilepsy - National Centre for Epilepsy Complex epilepsy .................................................................................................................................... 11 Group Leader: Morten Lossius Department of Neurosurgery Neurovascular-Hydrocephalus Research Group ..................................................................................... 16 Group Leader: Per Kristian Eide Oslo Neurosurgical Outcome Study Group (ONOSG) ................................................................................. 19 Group Leaders: Eirik Helseth and Torstein
    [Show full text]
  • Vascular Inflammation in Rheumatic And
    Vascular Inflammation in Rheumatic and Non- rheumatic Patients: A Controlled Study of Biopsy Specimens Obtained During Coronary Artery Surgery (Feiring Heart Biopsy Study) Doctoral thesis by Ivana Hollan Hospital for Rheumatic Diseases, Lillehammer, Norway The Feiring Heart Clinic, Feiring, Norway Rikshospitalet-Radiumhospitalet University Hospital, Oslo, Norway University of Oslo, Norway 2009 ISBN 978-82-8072-766-4 © Ivana Hollan, 2009 Series of dissertations submitted to the Faculty of Medicine, University of Oslo No. 779 ISBN 978-82- 8072-766-4 All rights reserved. No part of this publication may be reproduced or transmitted, in any form or by any means, without permission. Cover: Inger Sandved Anfinsen. Printed in Norway: AiT e-dit AS, Oslo, 2009. Produced in co-operation with Unipub AS. The thesis is produced by Unipub AS merely in connection with the thesis defence. Kindly direct all inquiries regarding the thesis to the copyright holder or the unit which grants the doctorate. Unipub AS is owned by The University Foundation for Student Life (SiO) 3 Imagination is more important than knowledge. For knowledge is limited to all we now know and understand, while imagination embraces the entire world, and all there ever will be to know and understand. Albert Einstein (1879-1955) 4 Content Acknowledgements 6 Abbreviations 8 List of papers 9 1. Introduction 10 1.1 Cardiovascular complications in inflammatory rheumatic diseases 10 1.1.1 Coronary artery disease in inflammatory rheumatic diseases 10 1.1.2 Cardiac involvement in spondyloarthritides 11 1.2 Causes of vascular lumen narrowing 11 1.2.1 Aortic and cardiac vasculitis 12 1.2.2 Diagnostic challenges in detecting aortic and cardiac vasculitis 13 1.3 Link between atherosclerosis and inflammation 14 1.4 Resistance to atherosclerosis in different vessels 16 1.5 The driving force behind the study 16 2.
    [Show full text]
  • Adolescent Body Composition, and Associations with Body Size and Growth from Birth to Late Adolescence
    Adolescent body composition, and associations with body size and growth from birth to late adolescence. The Tromsø Study: Fit Futures – a Norwegian longitudinal cohort study. Elin Evensen1, 2, Nina Emaus2, Anne-Sofie Furberg3, 4, Ane Kokkvoll5, Jonathan Wells6, Tom Wilsgaard3, 1, Anne Winther7, Guri Skeie3 1 Department of Clinical Research, University Hospital of North Norway, Tromsø, Norway 2 Department of Health and Care Sciences, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway 3 Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway 4 Department of Microbiology and Infection Control, University Hospital of North Norway, Tromsø, Norway 5 Department of Paediatrics, Finnmark Hospital Trust, Hammerfest, Norway 6 Childhood Nutrition Research Centre, UCL Great Ormond Street, Institute of Child Health, London, UK 7 Division of Neurosciences, Orthopedics and Rehabilitation Services, University Hospital of North Norway, Tromsø, Norway Running head: Childhood growth and adolescent body composition KEYWORDS: BODY COMPOSITION, FAT MASS INDEX, DUAL-ENERGY X-RAY ABSORPTIOMETRY, BIRTH WEIGHT, CHILDREN, ADOLESCENTS Corresponding author: Elin Kristin Evensen Department of Clinical Research, Post box 78, University Hospital of North Norway N-9038 Tromsø, Norway [email protected] mobile phone +47 95 92 23 13 ORCID: 0000-0002-5962-6695 ABSTRACT Background: Fat- and fat-free masses and fat distribution are related to cardio-metabolic risk. Objectives: To explore how birth weight, childhood body mass index (BMI) and BMI gain were related to adolescent body composition and central obesity. Methods: In a population-based longitudinal study, body composition was measured by dual- energy X-ray absorptiometry in 907 Norwegian adolescents (48% girls).
    [Show full text]
  • Perinatal Depression and Anxiety in Women with Multiple Sclerosis: a Population-Based Cohort Study
    Published Ahead of Print on April 21, 2021 as 10.1212/WNL.0000000000012062 Neurology Publish Ahead of Print DOI: 10.1212/WNL.0000000000012062 Perinatal Depression and Anxiety in Women with Multiple Sclerosis: A Population-Based Cohort Study Author(s): Karine Eid, MD1,2; Øivind Fredvik Torkildsen, MD PhD1,3; Jan Aarseth, PhD3,4,5; Heidi Øyen Flemmen, MD6; Trygve Holmøy, MD PhD7,8; Åslaug Rudjord Lorentzen, MD PhD9; Kjell-Morten Myhr, MD PhD1,3; Trond Riise, PhD3,5,10; Cecilia Simonsen, MD8,11; Cecilie Fredvik Torkildsen, MD1,12; Stig Wergeland, MD PhD2,3,4; Johannes Sverre 13,14 15 1,2 1,2 Willumsen, MD ; Nina Øksendal, MD ; Nils Erik Gilhus, MD PhD ; Marte-Helene Bjørk, MD PhD Note 1. The Article Processing Charge was funded by the Western Norway Regional Health Authority. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial- NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. Neurology® Published Ahead of Print articles have been peer reviewed and accepted for publication. This manuscript will be published in its final form after copyediting, page composition, and review of proofs. Errors that could affect the content may be corrected during these processes. Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. Corresponding Author: Karine Eid [email protected] Affiliation Information for All Authors: 1.
    [Show full text]
  • Evaluation of Remdesivir and Hydroxychloroquine on Viral Clearance in Covid-19 Patients: Results from the NOR-Solidarity Randomised Trial
    Evaluation of remdesivir and hydroxychloroquine on viral clearance in Covid-19 patients: Results from the NOR-Solidarity Randomised Trial Andreas Barratt-Due1,2,9,*, Inge Christoffer Olsen3, Katerina Nezvalova Henriksen4,5, Trine Kåsine1,9, Fridtjof Lund-Johansen2,6, Hedda Hoel7,9,10, Aleksander Rygh Holten8,9, Anders Tveita11, Alexander Mathiessen12, Mette Haugli13, Ragnhild Eiken14, Anders Benjamin Kildal15, Åse Berg16, Asgeir Johannessen9,17, Lars Heggelund18,19, Tuva Børresdatter Dahl1,10, Karoline Hansen Skåra10, Pawel Mielnik20, Lan Ai Kieu Le21, Lars Thoresen22, Gernot Ernst23, Dag Arne Lihaug Hoff24, Hilde Skudal25, Bård Reiakvam Kittang26, Roy Bjørkholt Olsen27, Birgitte Tholin28, Carl Magnus Ystrøm29, Nina Vibeche Skei30, Trung Tran2, Susanne Dudman9,39, Jan Terje Andersen9,31, Raisa Hannula32, Olav Dalgard9,33, Ane-Kristine Finbråten7,34, Kristian Tonby9,35, Bjorn Blomberg36,37, Saad Aballi38, Cathrine Fladeby39, Anne Steffensen9, Fredrik Müller9,39, Anne Ma Dyrhol-Riise9,35, Marius Trøseid9,40 and Pål Aukrust9,10,40 on behalf of the NOR-Solidarity study group# 1Division of Critical Care and Emergencies, Oslo University Hospital, 0424 Oslo, Norway 2Division of laboratory Medicine, Dept. of Immunology, Oslo University Hospital, 0424 Oslo, Norway 3Department of Research Support for Clinical Trials, Oslo University Hospital, 0424 Oslo, Norway 4Department of Haematology, Oslo University Hospital, 0424 Oslo, Norway 5Hospital Pharmacies, South-Eastern Norway Enterprise, 0050 Oslo, Norway 6ImmunoLingo Covergence Centre, University
    [Show full text]
  • THE NORTHERN NORWAY REGIONAL HEALTH AUTHORITY (Helse Nord RHF)
    THE NORTHERN NORWAY REGIONAL HEALTH AUTHORITY (Helse Nord RHF) Northern Norway Regional Health Authority (Helse Nord RHF) is responsible for the public hospitals in northern Norway. The hospitals are organised in five trusts: • Finnmark Hospital Trust • University Hospital of Northern Norway Trust • Nordland Hospital Trust • Helgeland Hospital Trust • Hospital Pharmacy of North Norway Trust The trusts have their own management boards and are independent legal entities. Sector Healthcare Locations The four hospital Trusts are located in all of North Norway and Svalbard. Size Enterprise Data 5000 users since its launch in early 2011, will scale to approx. 12,500 users by the end of 2014. Company Website www.helse-nord.no For Reference Trond Kristiansen, E-Learning advisor. Nordland Hospital Trust Email - [email protected] Tel. +47 470 12 344 Øystein Lorentzen, Manager for IT Nordland Hospital Trust Email - [email protected] Tel. +47 900 40 566 THE NORTHERN NORWAY REGIONAL HEALTH AUTHORITY (Helse Nord RHF) Case Study Copyright © 2013 Docebo S.p.A. All rights reserved. Docebo is either a registered trademark or trademark of Docebo S.p.A. Other marks are the properties of their respective owners. To contact Docebo, please visit: www.docebo.com Company Customer Challenge The Northern Norway Regional Hospitals are often large and very Health Authority (Helse Nord RHF) complex organizations and is responsible for the public Docebo’s functionality fulfills many hospitals in northern Norway. of our needs right out of the box. The Regional Health Authority was Only basic customization with little established on the 1st January or no development is needed to "THROUGH COOPERATION 2002 when the central government implement the Docebo solution.
    [Show full text]
  • Betydningen Av Komorbiditet, Kosten Og Medisiner
    PRESENTASJON AV PROSJEKTER I PARALLELLSESJONER 1* Tarmfloraen hos personer med sykelig overvekt; betydningen av komorbiditet, kosten og medisiner Per G. Farup1)2), Anne Stine Kvehaugen3), Martin Aasbrenn2)3) 1)Forskningsavdelingen, Sykehuset Innlandet HF, Brumunddal. 2)Enhet for anvendt klinisk forskning, Institutt for klinisk og molekylær medisin, Fakultet for medisin og helsefag, NTNU, Trondheim. 3)Kirurgisk avdeling, Sykehuset Innlandet HF, Gjøvik. Bakgrunn: En unormal tarmflora (fekal dysbiose) er vanlig hos personer med sykelig overvekt. Tarmfloraen regulerer energimetabolismen og fekal dysbiose kan være en årsak til både fedme og noe av den komorbiditet som er hyppig hos personer med sykelig overvekt. Mål/Hensikt: Studere forekomsten av fekal dysbiose og faktorer assosiert med fekal dysbiose hos personer med sykelig overvekt. Materiale og metode: Pasienter med BMI > 40 eller BMI > 35 kg/m2 med komplikasjoner ble vurdert for inklusjon. Bruk av medisiner ble notert, og kostholdet ble registrert med et validert matvarefrekvensskjema som inkluderte bruk av kunstige søtningsmidler (KS). En enhet KS ble definert som 100 ml drikke med KS eller to suketter. Fekal dysbiose ble målt med GA-map™ Dysbiosis Test (Genetic Analysis, Oslo, Norway) og angitt som Dysbiose Index (DI) skår 1-5, skår ≤2 er normalt. Resultatene er angitt som gjennomsnitt med SD, korrelasjoner og p-verdier. Resultater: Av totalt 350 fortløpende pasienter samtykket 159 til deltagelse og 104 leverte avføringsprøver (menn/kvinner: 18(17%)/86(83%); alder (SD): 44 (9) år). Dysbiose (DI skår > 2) ble påvist hos 67 (64%) pasienter. DI-skår:1-5 ble funnet hos henholdsvis 20 (19%), 18 (17%), 35 (34%), 14 (14%) and 17 (16%) pasienter.
    [Show full text]
  • Innkalling Og Forslag Til Saksliste HO21-Rådsmøte 28.02
    Til HelseOmsorg21-rådet Vår saksbehandler/tlf. Vår ref. Oslo, Hilde D.G. Nielsen, +4740922260/[email protected] 19/375 18.2.2019 Innkalling til HelseOmsorg21-rådsmøte 28.2.2019 (01/19) Vedlagt følger forslag til saksliste og sakspapirer til møte i HelseOmsorg21-rådet torsdag 28.2.2019 (01/19). Tid: kl 10.00 – 15.30. Sted: Forskningsrådet, Drammensveien 288, Lysaker. Vel møtt! Med vennlig hilsen Norges forskningsråd HelseOmsorg21-sekretariatet Hilde D. G. Nielsen, sekretariatsleder/spesialrådgiver Møte i HelseOmsorg21-rådet (01/19) Dato: Torsdag 28. februar 2019, kl 10.00 – 15.30 Sted: Forskningsrådet, Lysaker, møterom Abel 1 og 2 Saksliste Kl 10.00 – 10.15 Sak 01/19 Godkjenning av saksliste Sak 02/19 Godkjent referat Sak 03/19 Orienteringer Kl 10.15 – 11.00 Sak 04/19 Kunnskapssamarbeid med Kina Kl 11.00 – 12.00 Sak 05/19 Presentasjon og behandling av rapporten Research and Innovation for Better Health Lunsj kl 12.00-12.30 Kl 12.30 – 13.30 Sak 06/19 Presentasjon og behandling av sluttrapporten fra KSF Kort pause kl 13.30 – 13.45 Kl 13.45 - 14.45 Sak 07/19 HO21-rådets egenvurdering Kort pause kl 14.45 – 15.00 Kl 15.00 – 15.30 Sak 08/19 Orientering om status for arbeidet med stortingsmelding om innovasjon i offentlig sektor Kl 15.30 Sak 09/19 Eventuelt Saksfremlegg sak 02/19 – møte 01/19 Sak 02/19 Godkjent referat Type sak: Orienteringssak Til: HO21-rådet Fra: HO21-sekretariatsleder Hilde D.G. Nielsen Vedlegg: Godkjent referat fra møte 29.11.2018 (05/18) Referent: Sekretariatsleder Hilde D.G.
    [Show full text]